Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Last Close
2.80
Aug 25 • 1:07 PM ET Dollar change+0.01 Percentage change(0.36%)
Index
-
Market Cap
18.20M
Enterprise Value
-3.05M
Income
-4.23M
Sales
12.00M
Book/sh
4.01
Cash/sh
3.34
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
63
IPO
Jan 21, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
1.52
P/B
0.70
P/C
0.84
P/FCF
-
EV/EBITDA
-
EV/Sales
-0.25
Quick Ratio
7.22
Current Ratio
7.88
Debt/Eq
0.02
LT Debt/Eq
0.01
Option/Short
No / Yes
EPS (ttm)
-0.66
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
13.21% -1.94%
Sales past 3/5Y
14.32% -
EPS Y/Y TTM
58.17%
Sales Y/Y TTM
360.00%
EPS Q/Q
137.89%
Sales Q/Q
660.33%
Insider Own
40.65%
Insider Trans
0.00%
Inst Own
8.05%
Inst Trans
1.38%
ROA
-11.94%
ROE
-16.07%
ROIC
-16.13%
Gross Margin
84.54%
Oper. Margin
-26.48%
Profit Margin
-35.26%
SMA20
-11.94%
SMA50
-26.08%
SMA200
-33.61%
Trades
Shs Outstand
6.50M
Shs Float
3.86M
52W High
12.97 -78.41%
52W Low
2.75 1.82%
Volatility
8.68% 8.53%
ATR (14)
0.35
RSI (14)
34.06
Beta
-
Rel Volume
0.04
Avg Volume
1.41M
Volume
32,571
Perf Week
-2.44%
Perf Month
-15.41%
Perf Quarter
-38.19%
Perf Half Y
-44.55%
Perf YTD
-70.37%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
2.79
Price
2.80
Change %
0.36%
Aug-24-26 07:00AM
Aug-19-26 07:00AM
Aug-17-26 07:00AM
Jul-13-26 08:53AM
07:00AM
08:00AM Loading…
Jun-25-26 08:00AM
Jun-24-26 11:45AM
07:00AM
Mar-30-26 08:29AM
Mar-25-26 08:00AM
Feb-09-26 07:00AM
Feb-02-26 07:13AM
Jan-26-26 07:30AM
Jan-23-26 10:06AM
Jan-21-26 07:30AM
Pulsenmore Ltd. engages in research and development, production, marketing, and sale of self-scan ultrasound devices for remote clinical diagnosis and screening. It also offers a mobile app that guides the patient through a self-scan and enables online consolation with a clinician; as well as a clinician dashboard that allows clinicians to review scans and interacts with the patient remotely. The company was founded by Elazar Sonnenschein on October 27, 2014 and is headquartered in Omer, Israel.
FounderDr. Elazar Sonnenschein
Chief Financial OfficerMr. Eran Hirsh
Vice President of R&DMr. Minelu Sonnenschein
Vice President of Software DevelopmentMr. Meir Shmouely
General Counsel & Company SecretaryMr. Michael Hamelsdorf